VPipe: an Automated Bioinformatics Platform for Assembly and Management of Viral Next-Generation Sequencing DataMICROBIOLOGY SPECTRUMIF3.82022-04-279OAAI
Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and ZanamivirJOURNAL OF INFECTIOUS DISEASESIF4.52015-05-0550OAAI
Application of a Seven-Target Pyrosequencing Assay To Improve the Detection of Neuraminidase Inhibitor-Resistant Influenza A(H3N2) VirusesANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52015-04-019OAAI
Oseltamivir-Resistant Influenza A(H1N1) pdm09 Viruses, United States, 2013-14EMERGING INFECTIOUS DISEASESIF6.62015-01-0141OAAI
Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteriaINFLUENZA AND OTHER RESPIRATORY VIRUSESIF4.22013-12-0240OAAI
Cell Culture-Selected Substitutions in Influenza A(H3N2) Neuraminidase Affect Drug Susceptibility AssessmentANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52013-12-0139OA
Bioluminescence-Based Neuraminidase Inhibition Assay for Monitoring Influenza Virus Drug Susceptibility in Clinical SpecimensANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52013-11-0112OAAI
Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitorsINFLUENZA AND OTHER RESPIRATORY VIRUSESIF4.22012-12-2888OA
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010-11EMERGING INFECTIOUS DISEASESIF6.62012-02-0195OAAI
Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective. (vol 2, pg 2269 2010)VIRUSES-BASELIF3.52011-08-120OAAI
Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United StatesEMERGING INFECTIOUS DISEASESIF6.62011-02-0163OAAI
Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance PerspectiveVIRUSES-BASELIF3.52010-10-1383OAAI
Detection of E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir ResistanceANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52010-05-0182OAAI
Detection of Molecular Markers of Drug Resistance in 2009 Pandemic Influenza A (H1N1) Viruses by PyrosequencingANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52010-03-01107OAAI
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008ANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52008-09-01471OAAI
Modeling inheritance of malignant melanoma with DNA markers in Sinclair swineGENETICSIF5.12007-05-018OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向